Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Waiting For Blockbusters: Osteoporosis Market Burdened With Black Box Warnings, Reimbursement Woes, And Spare Pipelines

02 Jan 2012

• By Malorye Allison

Related Content

Warner Chilcott’s Launch Of Atelvia Hits Headwinds

27 Jun 2011

Second Tranche Of $91 Million Venture Round Will Help Advance Two Formulations Of Radius’ Osteoporosis Drug

23 Nov 2011

Pay-for-Performance in the US: What Could Work, What Won't

01 Jan 2010

Prolia Pricing: Straddling Osteoporosis And Oncology

07 Jun 2010

Related Companies

Eli Lilly and Company

Amgen, Inc.

Warner Chilcott PLC

Roche Holding AG

Novartis AG

Pfizer Inc.

Ligand Pharmaceuticals, Inc.

Zosano Pharma Corporation

Radius Health, Inc.

UCB S.A.

Emisphere Technologies, Inc.

GSK plc

Sanofi

Additional Topics

United States Europe Japan Asia Pacific BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.